1. REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy
   Huibo Wang et al, 2009 CrossRef
2. Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line
   Wei Zhang et al, 2001 CrossRef
3. DNA Polymerases and Human Diseases
   Joann B. Sweasy et al, 2006, Radiation Research CrossRef
4. DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair
   Xinjian Lin et al, 2006 CrossRef